Prof Ifeoma Okoye speaks to ecancer at the 2019 American Association for Cancer Research (AACR) meeting about her advocacy for improved cancer control and for more clinical trials in Africa.

Prof Okoye also explains the epidemiological burden that Africa are currently experiencing with the high prevalence of communicable diseases.

Prof Okoye highlights the significance of clinical trials and genome-wide studies, as a method to identify the genetic and environmental drivers of cancer in the population.